Avifavir, developed by a joint venture of the Russian Direct Investment Fund and ChemRar Group, is designed to disrupt the novel coronavirus’s ability to reproduce and has proven effective in clinical trials. A researcher sounded a note of caution while the head of the wealth fund said it’s a potential breakthrough.
In this day and age, understanding bacteria and viruses and developing vaccines are national security issues. In my view sizable part of every country’s defense budget should be spent in these pursuits rather than making tanks and other weapons.
DAILY NEW CASES AND DEATHS IN US, CDC SITE